Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative Colitis

NCT00408629 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

518

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

BIOLOGICAL: adalimumab
BIOLOGICAL: placebo

Sponsor

Abbott